FundingWatcher
Home / Investors / Biotech investors

Biotech investors

Updated 16 Nov 2026

Reset

Venture funds

50 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 SOSV
SOSV provides early-stage funding for healthcare and environmental technologies, with recent investments including Opentrons and Prolific Machines.
Princeton, United States
Hardware, Artificial intelligence Seed, Early stage venture 41% 17
2 SOSV SF & NY (Fka IndieBio)
SOSV SF & NY, formerly IndieBio, supports deep tech founders, with recent investments including Prolific Machines and heXem bio.
San Francisco, United States
Biotech, Health care Seed, Early stage venture 3% 14
3 Qiming Venture Partners
Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio.
Shanghai, China
Health care, Artificial intelligence Seed, Early stage venture, Late stage venture 50% 11
4 Innovate UK
Innovate UK runs funding competitions for businesses and research organizations in emerging technologies, with recent awardees including Ryft and Concretene.
Swindon, United Kingdom
Artificial intelligence, Health care 75% 8
5 Alumni Ventures
Alumni Ventures offers accredited investors diversified startup portfolios, with recent investments including Coframe and Ocient.
Manchester, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 1% 7
6 Khosla Ventures
Khosla Ventures backs AI, sustainability, health and frontier technologies, with recent investments including Opentrons and Ramp.
Menlo Park, United States
Artificial intelligence, Health care Seed, Early stage venture, Late stage venture 39% 7
7 Legend Capital
Legend Capital invests in China, with recent investments including Infinigence and Sinsegye.
Beijing, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 42% 7
8 Alexandria Venture Investments
Alexandria Venture Investments invests in real estate technology and healthcare, with recent investments including Lycia Therapeutics and Aspen Neuroscience.
Pasadena, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 7% 5
9 HTGF (High-Tech Gruenderfonds)
HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate.
Bonn, Germany
Biotech, Health care Seed, Early stage venture, Late stage venture 28% 5
10 ANRI
ANRI is a Japanese venture firm mainly investing in seed and early-stage startups, recently backing Craif and LAMP Japan.
Tokyo, Japan
Health care, Artificial intelligence Seed, Early stage venture, Late stage venture 26% 4
11 Mission BioCapital
Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio.
Cambridge, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 20% 4
12 BioVenture
BioVenture offers early and growth stage investment, with recent investments including AusperBio and Degron Therapeutics.
Suzhou, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 4
13 Bristol-Myers Squibb
Bristol-Myers Squibb develops and sells pharmaceuticals, with recent investments including BigHat Biosciences and Ratio Therapeutics.
New York, United States
Biotech, Health care Early stage venture 30% 4
14 Gaingels
Gaingels funds startups and supports diversity and inclusion in entrepreneurship, with recent investments including Delix Therapeutics and Ocient.
Burlington, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 1% 4
15 Google Ventures
Google Ventures provides seed through growth-stage funding to technology companies, with recent investments including Harvey and SambaNova.
San Francisco, United States
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 4
16 K2VC
K2VC invests in early stage technology startups, including Shexu Technology and Startorus Fusion.
Beijing, China
Commerce, Fintech Seed, Early stage venture 22% 4
17 Novo Holdings
Novo Holdings invests in life science companies, with recent companies including Claris Biotherapeutics and Windward Bio.
Hellerup, Denmark
Health care, Biotech Seed, Early stage venture, Late stage venture 36% 4
18 Sofinnova Partners
Sofinnova Partners invests in life sciences from seed to later stage, including T-Therapeutics, Mironid and DISCO Pharmaceuticals.
Paris, France
Biotech, Health care Seed, Early stage venture, Late stage venture 44% 4
19 ARCH Venture Partners
ARCH Venture Partners focuses on life science discoveries to prevent, detect and cure disease, with recent companies including Moonwalk Biosciences and Mirador Therapeutics.
Chicago, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 27% 3
20 Gaorong Capital
Gaorong Capital focuses on TMT investments including AI and frontier technologies, including BioGeometry and Raysolve.
Wangjing, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 3
21 BlueYard Capital
BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio.
Berlin, Germany
Fintech, Biotech Seed, Early stage venture 41% 3
22 Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix.
Ingelheim Am Rhein, Germany
Biotech, Health care Seed, Early stage venture 47% 3
23 Conscience VC
Conscience VC invests in science, with recent companies Tiny Health and Integrated Biosciences.
Austin, United States
Health care, Biotech Seed, Early stage venture 8% 3
24 Fifty Years
Fifty Years backs entrepreneurs solving the world's biggest problems, recently investing in Multiply Labs and Aalo Atomics.
San Francisco, United States
Artificial intelligence, Health care Seed, Early stage venture, Late stage venture 19% 3
25 Global Brain Corporation
Global Brain Corporation invests from seed or early stage to pre-IPO, with recent investments including Newmo and Zafrens.
Tokyo, Japan
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 31% 3
26 Haitang Fund
Haitang Fund is a venture fund founded by Tianjin University alumni entrepreneurs, with recent investments in Zhonghe Gene and Xingsai Bio.
Nankai, China
Biotech, Health care Early stage venture 30% 3
27 Hummingbird Ventures
Hummingbird Ventures backs outlier founders globally, recently investing in Etched and Lovable.
Brussels, Belgium
Artificial intelligence, Biotech Seed, Early stage venture 28% 3
28 IDG Capital
IDG Capital funds early- to growth-stage technology companies, with recent investments including Zero Zero Robotics and XPENG Robotics.
Beijing, China
Hardware, Fintech Seed, Early stage venture, Late stage venture 36% 3
29 Joyance Partners
Joyance Partners invests in companies using science and technology to cultivate joy, with recent investments including Mosh and Sparxell.
San Francisco, United States
Health care, Biotech Seed, Early stage venture 8% 3
30 Matrix Partners China
Matrix Partners China builds long-term relationships with entrepreneurs in China, with recent investments including Houmo.AI and Astribot.
Beijing, China
Artificial intelligence, Hardware Early stage venture 34% 3
31 Med-Fine Capital
Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma.
Shanghai, China
Health care, Biotech Early stage venture 30% 3
32 Modi Ventures
Modi Ventures focuses on investing into the next frontier, and recently backed Tiny Health and Latus Bio.
Houston, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 14% 3
33 Pfizer
Pfizer is a biopharmaceutical company developing medicines and vaccines, with recent companies including Circle Pharma, CellCentric and FoRx Therapeutics.
New York, United States
Biotech, Health care 40% 3
34 Shenzhen Capital Group
Shenzhen Capital Group focuses on cultivating national industries and national brands, with recent investments including SAGE Intelligent and Chasing Innovation.
Nanshan, China
Hardware, Health care Seed, Early stage venture, Late stage venture 40% 3
35 Shunwei Capital
Shunwei Capital focuses on China's internet industry at early to mid stages, with recent companies including SAGE Intelligent and Hooke Instruments.
Beijing, China
Hardware, Commerce Seed, Early stage venture, Late stage venture 31% 3
36 The Column Group
The Column Group is a venture firm dedicated to biotechnology companies, with recent companies including Circle Pharma, InduPro and Atavistik Bio.
San Francisco, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 39% 3
37 2048 Ventures
2048 Ventures is a thesis-driven venture firm, recently backing TwoStep Therapeutics and Genius AI.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture 67% 2
38 8VC
8VC structures capital deployments for technology companies, with recent investments including Sirona Medical and BigHat Biosciences.
Austin, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 30% 2
39 Alpha Wave Global
Alpha Wave Global operates across private equity, private credit, public markets and insurance, with recent investments in Moonwalk Biosciences and Cour Pharmaceuticals Development.
Miami, United States
Fintech, Artificial intelligence Seed, Early stage venture, Late stage venture 54% 2
40 Artis Ventures
Artis Ventures invests in companies at the intersection of technology, health and biology, including Delix Therapeutics and Ozlo Sleep.
San Francisco, United States
Health care, Hardware Seed, Early stage venture, Late stage venture 35% 2
41 Astanor Ventures
Astanor Ventures backs entrepreneurs regenerating food, the blue ocean economy and agriculture, with recent companies BioFluff and Standing Ovation.
Luxembourg, Belgium
Artificial intelligence, Biotech Seed, Early stage venture, Late stage venture 55% 2
42 BioTrack Capital
BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 2
43 BoxGroup
BoxGroup invests in early-stage technology companies, with recent investments including Nominal and Northwood Space.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture 5% 2
44 Boyuan Capital
Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Late stage venture 38% 2
45 Breakthrough Energy Ventures
Breakthrough Energy Ventures targets reliable, affordable power without climate impact, recently backing Type One Energy and Antora Energy.
Paris, France
Energy, Artificial intelligence Seed, Early stage venture, Late stage venture 43% 2
46 Builders VC
Builders VC invests where technology meets new business models to modernize antiquated industries, including Clay and Pie Systems.
San Francisco, United States
Artificial intelligence, Health care Early stage venture 34% 2
47 Cambridge Innovation Capital
Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica.
Cambridge, United Kingdom
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 36% 2
48 Casdin Capital
Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care.
New York, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 15% 2
49 Chengdu Science and Technology Venture Capital
Chengdu Science and Technology Venture Capital is a venture firm with recent companies including Kunteng Tech, QL Biopharma and New Radiomedicine Technology.
Chengdu, China
Biotech, Health care Early stage venture, Late stage venture 36% 2
50 Coral Capital
Coral Capital invests at the seed stage with a full-service approach, with recent companies including Facilo, Dioseve and Cosomil.
Tokyo, Japan
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 2

Table 1. Biotech investors: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors
One-time CSV
  • 993 firms, 972 with a website
  • 704 firm email addresses
  • 639 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech.csv993 rows × 15 columns
InvestorTypeLocationEmailPhone
Y CombinatorStartup acceleratorMountain View, United States•••@ycombinator.com(415) •••
HTGF (High-Tech Gruenderfonds)Venture capital firmBonn, Germany•••@htgf.de+49 22•••
SOSVVenture capital firmPrinceton, United States•••@sosv.com
National Science FoundationEntrepreneurship programAlexandria, United States•••@nsf.gov(703) •••
Venture KickStartup incubatorSchlieren, Switzerland•••@venturekick.ch+41 (2•••
RA Capital ManagementStartup incubatorBoston, United States•••@racap.com617.77•••
SOSV SF & NY (Fka IndieBio)Venture capital firmSan Francisco, United States•••@sosv.com
Alumni VenturesAngel groupManchester, United States•••@av.vc+1 603•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-sector-biotech-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
Y CombinatorG••• A•••General Partnerg•••@ycombinator.comIn the CSV
SOSVO••• R•••Managing General Partnero•••@sosv.comIn the CSV
RA Capital ManagementP••• K•••Managing Partnerp•••@racap.comIn the CSV
OrbiMedW••• P•••Managing Directorp•••@orbimed.comIn the CSV
TechstarsA••• B•••Managing Director NYC Programsa•••@techstars.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

993
Investors
704
With email
639
With phone
722
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors

30 of 993, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Y Combinator Startup accelerator Mountain View, United States Artificial intelligence, Fintech Kalshi, Opentrons, Reflex 225 8,719 3,692 783 •••@ycombinator.com (415) ••• In the CSV
2 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany Biotech, Health care Rabot Energy, CereGate, syte 17 1,026 290 136 •••@htgf.de +49 22••• In the CSV
3 SOSV Venture capital firm Princeton, United States Hardware, Artificial intelligence Opentrons, live2.ai, Prolific Machines 30 2,865 1,185 98 •••@sosv.com In the CSV
4 National Science Foundation Entrepreneurship program, Government investment office Alexandria, United States Hardware, Artificial intelligence Emvolon, Xona, MuukTest 36 4,642 4,419 269 •••@nsf.gov (703) ••• In the CSV
5 Venture Kick Startup incubator Schlieren, Switzerland Health care, Biotech UniSieve, Cotierra, Jaipur Robotics 13 1,459 1,342 82 •••@venturekick.ch +41 (2••• In the CSV
6 RA Capital Management Startup incubator, Private equity firm Boston, United States Health care, Biotech Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics 9 544 183 243 •••@racap.com 617.77••• In the CSV
7 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States Biotech, Health care Prolific Machines, heXem bio, BryoSphere 17 596 17 12 •••@sosv.com In the CSV
8 Alumni Ventures Angel group, Micro VC fund Manchester, United States Artificial intelligence, Fintech Coframe, Ocient, Formic 67 2,424 32 263 •••@av.vc +1 603••• In the CSV
9 OrbiMed Private equity firm New York, United States Health care, Biotech Triveni Bio, Windward Bio, Terremoto Biosciences 8 810 276 304 +1 (21••• In the CSV
10 MassChallenge Startup accelerator Boston, United States Artificial intelligence, Health care HELIOS, DrizzleX, ScribeUp 26 3,225 1,037 267 •••@masschallenge.org In the CSV
11 Techstars Startup accelerator New York, United States Artificial intelligence, Fintech Zipline International, Intuitivo, MuukTest 67 6,842 3,391 638 •••@techstars.com +1 303••• In the CSV
12 Innovate UK Entrepreneurship program, Venture capital firm Swindon, United Kingdom Artificial intelligence, Health care Bioliberty, Concretene, Doctoria LTD 27 1,307 976 84 •••@innovateuk.ukri.org In the CSV
13 Alexandria Venture Investments Venture capital firm Pasadena, United States Biotech, Health care TwoStep Therapeutics, Lycia Therapeutics, Triveni Bio 5 318 21 68 •••@gmail.com 626.57••• In the CSV
14 Plug and Play Startup accelerator, Co-working space Sunnyvale, United States Artificial intelligence, Fintech Opsin, Helical Fusion, Reco 51 2,592 352 230 •••@pnptc.com +1 408••• In the CSV
15 Bpifrance Government investment office, Investment bank Maisons-alfort, France Artificial intelligence, Hardware WORMSENSING, CarbonFarm Technology, Archeon 19 1,680 454 214 •••@bpifrance.fr +33 (0••• In the CSV
16 Qiming Venture Partners Venture capital firm Shanghai, China Health care, Artificial intelligence Houmo.AI, Infinigence, AusperBio 21 1,106 555 104 •••@qimingvc.com (+86) ••• In the CSV
17 European Innovation Council Startup accelerator Brussels, Belgium Hardware, Health care Onego Bio, Quantrol Ox, Cellbox Solutions 17 1,271 921 48 In the CSV
18 Creative Destruction Lab Entrepreneurship program, University program Toronto, Canada Artificial intelligence, Hardware Specific Biologics, Circuit Mind, Xona 21 788 215 87 •••@creativedestructionlab.com (404) ••• In the CSV
19 Forbion Capital Partners Private equity firm, Venture capital firm Naarden, The Netherlands Biotech, Health care Kynexis, Beacon Therapeutics 2 188 93 54 •••@forbion.com +31 35••• In the CSV
20 ARCH Venture Partners Venture capital firm Chicago, United States Health care, Biotech Moonwalk Biosciences, Moleculent, Mirador Therapeutics 3 535 147 121 •••@archventure.com 773-38••• In the CSV
21 Novo Holdings Corporate venture arm, Venture capital firm Hellerup, Denmark Health care, Biotech Claris Biotherapeutics, Windward Bio, Terremoto Biosciences 5 417 150 115 •••@novo.dk 45 35 ••• In the CSV
22 KfW Government investment office, Investment bank Frankfurt, Germany Biotech, Health care CryoTherapeutics, Vectoflow, HelloDuty 198 29 56 •••@kfw.de 49 69 ••• In the CSV
23 Andreessen Horowitz Venture capital firm Menlo Park, United States Artificial intelligence, Fintech Shield AI, Zipline International, Northwood Space 49 2,041 916 311 •••@a16z.com (650) ••• In the CSV
24 Khosla Ventures Venture capital firm Menlo Park, United States Artificial intelligence, Health care Coframe, Opentrons, Even Healthcare 25 1,479 575 208 •••@khoslaventures.com +1 650••• In the CSV
25 Google Ventures Corporate venture arm, Venture capital firm San Francisco, United States Artificial intelligence, Hardware Snorkel AI, Thatch, Harvey 20 1,331 392 304 In the CSV
26 National Institutes of Health Entrepreneurship program Bethesda, United States Health care, Biotech Ramona, Talus Bio, Samay 5 1,049 774 107 •••@od.nih.gov 301-49••• In the CSV
27 Bristol-Myers Squibb Venture capital firm New York, United States Biotech, Health care BigHat Biosciences, Ratio Therapeutics, Cour Pharmaceuticals Development 4 109 33 22 (212)5••• In the CSV
28 Sofinnova Partners Venture capital firm Paris, France Biotech, Health care T-Therapeutics, Mironid, Bon Vivant 5 373 164 76 •••@sofinnovapartners.com +33 (0••• In the CSV
29 Pioneer Fund Startup accelerator Toronto, Canada Artificial intelligence, Fintech Vera Health, Ultra, Talus Bio 35 860 12 34 •••@pioneerfund.vc In the CSV
30 EQT Life Sciences Private equity firm Amsterdam, The Netherlands Health care, Biotech FoRx Therapeutics 1 198 74 55 •••@lspvc.com +31 20••• In the CSV

Table 2. Biotech investors: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 993.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Y Combinator Mountain View, United States 225 3,060 Kalshi, Opentrons, Reflex
2 Alumni Ventures Manchester, United States 67 696 Coframe, Ocient, Formic
3 Techstars New York, United States 67 2,132 Zipline International, Intuitivo, MuukTest
4 Plug and Play Sunnyvale, United States 51 740 Opsin, Helical Fusion, Reco
5 Andreessen Horowitz Menlo Park, United States 49 462 Shield AI, Zipline International, Northwood Space
6 Antler Singapore 44 831 Futuriza, AirDodge AS, Satlyt
7 General Catalyst San Francisco, United States 38 344 Nominal, Tractian, StockGro
8 National Science Foundation Alexandria, United States 36 244 Emvolon, Xona, MuukTest
9 Pioneer Fund Toronto, Canada 35 290 Vera Health, Ultra, Talus Bio
10 Sequoia Capital Menlo Park, United States 32 429 Zipline International, Kalshi, Hex Technologies
11 Lightspeed Venture Partners Menlo Park, United States 31 378 Casap, Supabase, Snorkel AI
12 SOSV Princeton, United States 30 356 Opentrons, live2.ai, Prolific Machines
13 Tiger Global Management New York, United States 27 289 Harbinger, Easol, Mach9
14 500 Global Palo Alto, United States 27 1,023 Takenos, Daytona, Salary Hero
15 Innovate UK Swindon, United Kingdom 27 163 Bioliberty, Concretene, Doctoria LTD

Table 3. Biotech investors: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Sciphage Sciphage develops natural functional alternatives that reduce the use of antibiotics. Biotech Bogotá, Colombia Seed $107K 2026-11-11 $107K The Ganesha Lab 11 to 50 2014
Light Frame Light Frame builds core banking and portfolio management technology for wealth managers. Fintech Providence, United States Seed $5.1M 2026-11-10 $6.8M Half Court Ventures 1 to 10 2024
Nominal Nominal develops software platforms that help hardware engineering teams test, monitor, and analyze operational data. Software Los Angeles, United States Series C $240.0M 2026-11-09 $422.5M General Catalyst, Founders Fund, Lux Capital +2 251 to 500 2022
Newmo Newmo develops a ride-sharing platform that provides transportation to local communities and consumers. Software Minato, Japan Series B $131.5M 2026-11-09 $255.1M Global Brain Corporation, SMBC Venture Capital, Mizuho Capital +1 51 to 100 2024
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M RA Capital Management, Dolby Family Ventures, Artis Ventures +1 11 to 50 2019
Huasaiboman Medical Cell Biology Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. Biotech Qingdao Shi, China Series B $30.0M 2026-11-09 $30.0M ASBV 11 to 50 2019
Coframe Coframe builds software that continuously improves websites and apps based on real-world performance data. Artificial intelligence San Francisco, United States Series A $25.0M 2026-11-09 $34.3M Alumni Ventures, Khosla Ventures, Soma Capital 11 to 50 2023
Tushen Zhihe Tushen Zhihe provides artificial intelligence protein design services. Artificial intelligence Minhang, China Seed $1.4M 2026-11-09 $1.5M Wuxi Capital 11 to 50 2023
Shield AI Unicorn Shield AI develops AI-powered systems that enhance safety for service members and civilians. Artificial intelligence San Diego, United States Series H $2.0B 2026-11-05 $6.1B Andreessen Horowitz 1,001 to 5,000 2015
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Fidelity, Techstars, Andreessen Horowitz +2 1,001 to 5,000 2011

Table 4. Biotech investors: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 23,399 77%
Artificial intelligence 7,392 24%
Fintech 5,057 17%
Hardware 4,802 16%
Health care 4,049 13%
Commerce 3,333 11%
Biotech 1,822 6%
Education 1,577 5%
Cybersecurity 1,400 5%
Energy 663 2%

Table 5. Biotech investors: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Investment stagesInvestorsShare
Early stage investors 896 90%
Seed investors 753 76%
Late stage investors 520 52%
Venture investors 449 45%
Private equity investors 177 18%
Post IPO investors 134 13%
Convertible note investors 111 11%
Debt investors 92 9%

Table 6. Biotech investors by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
United States 441 44%
China 124 12%
United Kingdom 68 7%
Germany 60 6%
Switzerland 32 3%
Canada 27 3%
France 23 2%
South Korea 23 2%
Belgium 20 2%
Japan 18 2%
The Netherlands 14 1%
Singapore 13 1%

Table 7. Biotech investors by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
San Francisco 78 8%
New York 70 7%
Beijing 42 4%
London 40 4%
Boston 33 3%
Menlo Park 30 3%
Shanghai 24 2%
Palo Alto 24 2%
Paris 18 2%
Shenzhen 18 2%
Cambridge 17 2%
Seoul 16 2%

Table 8. Biotech investors by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 76 8%
2010s 434 45%
2000s 229 24%
1990s 112 12%
1980s 45 5%
1970s 19 2%

Table 9. Biotech investors by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors are on the list?
993, in the file dated 16 November 2026. 722 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
704 of the 993 carry an email address in the download and 639 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 993 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV with 993 rows, 704 firm email addresses and 639 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 483 of the 704 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors: 993 rows, CSV, $29 one-time.

At once: the CSV with 993 rows, 704 firm email addresses and 639 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 483 of the 704 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $349 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by location

Biotech investors by investor type

Investors in other sectors

Biotech startups

Cite: FundingWatcher, 993 biotech investors, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/